Company News

Share this article:

Sanofi-Aventis announced the acquisition of Medley, a Brazilian pharmaceutical manufacturer, for $658 million. The transaction is expected to be finalized during the second quarter of 2009. According to a Sanofi release, Medley is the third largest pharmaceutical company—and the largest generic manufacturer—in Brazil. Medley posted roughly $201 million in sales for 2008, according to the statement.

 

Takeda announced plans to expand sales and marketing operations in Spain and Ireland. In Spain, the company will commence with promotional activities in support of Blopress, a blood pressure drug, and Glustin, a diabetes treatment. In Ireland, the company expanded promotional activities for Actos, a treatment for type 2 diabetes.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.